T1	p 90 154	healthy volunteers and in patients with primary hypothyroidism .
T2	p 186 205	the pineal gland of
T3	p 372 392	secretion in man has
T4	p 474 550	8 healthy volunteers , and 6 women with untreated primary hypothyroidism , a
T5	p 812 835	healthy volunteers were
T6	p 1098 1114	healthy controls
T7	p 1243 1271	patients with hypothyroidism
T8	p 1909 1928	normal subjects and
T9	p 1932 1968	patients with primary hypothyroidism
T10	p 2074 2092	secretion in man .
T11	i 18 45	somatostatin ( octreotide )
T12	i 155 167	Somatostatin
T13	i 321 333	somatostatin
T14	i 622 633	melatonin .
T15	i 662 685	subcutaneous injections
T16	i 712 755	either saline or octreotide ( Sandostatin ;
T17	i 771 784	50 microg ) .
T18	i 842 852	octreotide
T19	i 855 864	melatonin
T20	i 929 937	saline .
T21	i 1126 1141	octreotide ( GH
T22	i 1173 1183	octreotide
T23	i 1188 1200	126.6+/-21.9
T24	i 1208 1209	h
T25	i 1329 1350	octreotide and saline
T26	i 1510 1526	octreotide ( TSH
T27	i 1557 1567	octreotide
T28	i 1572 1581	851+/-185
T29	i 1589 1590	h
T30	i 1645 1665	microg of octreotide
T31	i 1769 1770	.
T32	i 1777 1802	exogenous somatostatin --
T33	i 1818 1837	octreotide -- fails
T34	i 2014 2026	somatostatin
T35	o 599 608	nocturnal
T36	o 865 874	secretion
T37	o 947 954	urinary
T38	o 1046 1058	GH secretion
T39	o 1142 1145	AUC
T40	o 1353 1360	Urinary
T41	o 1420 1431	secretion .
T42	o 1436 1468	total nocturnal secretion of TSH
T43	o 1523 1530	TSH AUC
T44	o 1729 1737	function
T45	o 1851 1882	nocturnal secretion and urinary